Theralase Anti-Cancer Technology

  • Home
  • Theralase Anti-Cancer Technology

Theralase Anti-Cancer Technology Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Theralase Anti-Cancer Technology, Pharmaceuticals, .

A clinical-stage pharmaceutical company focused on R&D of PhotoDynamic therapy in Anti-Cancer treatment is quickly advancing on what may prove to be one of the safest and most effective cancer treatments ever developed.

04/07/2024

Q&A with Theralase® CEO from the Annual Shareholders meeting June 19th, 2024

06/06/2024

Q1 2024 Theralase® Quarterly Investor Call providing clinical study update and Q&A with the CEO

06/06/2024

Theralase® Q12024 Investor Quarterly call with clinical study update and Q&A with CEO

Theralase®'s "...lead compound, RuvidarTM, combined with transferrin to form the compound Rutherrin®, has been proven ef...
06/06/2024

Theralase®'s "...lead compound, RuvidarTM, combined with transferrin to form the compound Rutherrin®, has been proven effective preclinically in the destruction of Non-Small Cell Lung Cancer ("NSCLC").

TORONTO, ON / ACCESSWIRE / June 6, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF) is a clinical stage pharmaceutical company that is dedicated to the research and development of light and/or radiation activated small molecules for the safe and effective...

Theralase®'s RuvidarTM, has been proven to "...inactivate 90 to 99.9% of all seven viruses that we tested, including H1N...
06/06/2024

Theralase®'s RuvidarTM, has been proven to "...inactivate 90 to 99.9% of all seven viruses that we tested, including H1N1 influenza virus, coronavirus, Zika virus, poxvirus and herpes virus. In fact, RuvidarTM at 3 mM completely killed the herpes virus."

TORONTO, ON / ACCESSWIRE / June 4, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated small molecules for the safe and effective destructi...

05/04/2024

New to Theralase Anti-Cancer Technology; a Quarterly conference call to be held after all financial filings to review and provide corporate update

05/04/2024

Theralase Anti-Cancer Technology recording of 2023 Annual Financial Statement conference call.

27/03/2024

Theralase® Release’s 2023 Annual Financial Statements and clinical trial update

Address


Telephone

+18668435273

Website

Alerts

Be the first to know and let us send you an email when Theralase Anti-Cancer Technology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Theralase Anti-Cancer Technology:

Shortcuts

  • Want your practice to be the top-listed Clinic?

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram